| Antibody validation J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ... Biotechniques 48 (3), 197-209, 2010 | 754 | 2010 |
| Proinvasion metastasis drivers in early-stage melanoma are oncogenes KL Scott, C Nogueira, TP Heffernan, R van Doorn, S Dhakal, JA Hanna, ... Cancer cell 20 (1), 92-103, 2011 | 166 | 2011 |
| microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ... Cancer discovery 2 (8), 736-749, 2012 | 124 | 2012 |
| Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization JA Hanna, H Wimberly, S Kumar, F Slack, S Agarwal, DL Rimm Biotechniques 52 (4), 235-245, 2012 | 81 | 2012 |
| Stathmin expression and its relationship to microtubule‐associated protein tau and outcome in breast cancer MT Baquero, JA Hanna, V Neumeister, H Cheng, AM Molinaro, LN Harris, ... Cancer 118 (19), 4660-4669, 2012 | 80 | 2012 |
| Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors CJ Drummond, JA Hanna, MR Garcia, DJ Devine, AJ Heyrana, ... Cancer Cell 33 (1), 108-124. e5, 2018 | 73 | 2018 |
| In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA JA Hanna, L Hahn, S Agarwal, DL Rimm Laboratory investigation 92 (10), 1390-1397, 2012 | 73 | 2012 |
| PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma JA Hanna, MR Garcia, A Lardennois, PJ Leavey, D Maglic, A Fagnan, ... Oncogene 37 (15), 1991-2007, 2018 | 47 | 2018 |
| Quantitative assessment of miR34a as an independent prognostic marker in breast cancer S Agarwal, J Hanna, ME Sherman, J Figueroa, DL Rimm British journal of cancer 112 (1), 61-68, 2015 | 39 | 2015 |
| PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma JA Hanna, MR Garcia, JC Go, D Finkelstein, K Kodali, V Pagala, X Wang, ... Cell Death & Disease 7 (6), e2256-e2256, 2016 | 35 | 2016 |
| The function, proteolytic processing, and histopathology of Met in cancer JA Hanna, J Bordeaux, DL Rimm, S Agarwal Advances in cancer research 103, 1-23, 2009 | 31 | 2009 |
| Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity CG Langdon, KE Gadek, MR Garcia, MK Evans, KB Reed, M Bush, ... Nature communications 12 (1), 5520, 2021 | 16 | 2021 |
| Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma JA Hanna, CJ Drummond, MR Garcia, JC Go, D Finkelstein, JE Rehg, ... Cancer research 77 (22), 6109-6118, 2017 | 15 | 2017 |
| BRCA1 protein expression predicts survival in glioblastoma patients from an NRG oncology RTOG cohort M Vassilakopoulou, M Won, WJ Curran, L Souhami, MD Prados, ... Oncology 99 (9), 580-588, 2021 | 6 | 2021 |
| Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2‐Cre mice JA Hanna, CG Langdon, MR Garcia, A Benton, NA Lanman, D Finkelstein, ... The Journal of Pathology, 2022 | 3 | 2022 |
| GENO-21 BRCA1 protein expression predicts survival in glioblastoma patients from a NRG Oncology/RTOG cohort M Vassilakopoulou, M Won, W Curran, L Souhami, M Prados, C Langer, ... Neuro-oncology 17 (suppl_5), v96-v96, 2015 | 2 | 2015 |
| BRCA1 protein expression predicts survival in glioblastoma multiforme (GBM) patients from a RTOG Cohort M Vassilakopoulou, M Won, WJ Curran, L Souhami, M Prados, C Langer, ... International Journal of Radiation Oncology, Biology, Physics 93 (3), S141, 2015 | 1 | 2015 |
| Germline DICER1 loss promotes rhabdomyosarcoma via innate immune system R Larsen, J Hanna, K Reed, H Jin, W Kimbrough, K Vuong, M Evans, ... Cancer Research 84 (6_Supplement), 5463-5463, 2024 | | 2024 |
| Target gene regulatory network of miR-497 in angiosarcoma A Benton, E Terwilliger, NM Moriarty, B Liu, A Murphy, H Maluvac, M Shu, ... bioRxiv, 2023 | | 2023 |
| Abstract IA013: Rhabdomyosarcoma: visions through the looking glass ME Hatley, CG Langdon, KE Gadek, MR Garcia, CJ Drummond, ... Clinical Cancer Research 28 (18_Supplement), IA013-IA013, 2022 | | 2022 |
